Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$0 Mln
Revenue (TTM)
$1 Mln
Net Profit (TTM)
$0 Mln
ROE
-10.1 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
0.4
Industry P/E
--
EV/EBITDA
0.2
Div. Yield
0 %
Debt to Equity
-1.4
Book Value
$--
EPS
$-35.8
Face value
--
Shares outstanding
863,788
CFO
$-447.81 Mln
EBITDA
$-490.56 Mln
Net Profit
$-508.41 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Trevena (TRVN)
| -7.5 | 0.9 | -7.5 | -99.1 | -91.4 | -90.1 | -73.0 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Trevena (TRVN)
| -99.2 | -91.6 | -49.5 | -90.2 | -72.8 | 154.5 | 95.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Trevena (TRVN)
|
0.0 | 0.0 | 0.6 | -34.0 | -3,005.9 | -- | -- | 0.4 |
| 61.0 | 8,072.9 | 1,091.0 | 202.3 | 31.6 | 31.3 | 36 | 14.2 | |
| 229.3 | 13,405.2 | 691.7 | -219.0 | -13.7 | 163.2 | -- | 14.6 | |
| 66.7 | 7,755.6 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.3 | |
| 43.9 | 11,247.3 | 2,320.1 | 782.6 | 39.0 | 35.5 | 14.9 | 5.0 | |
| 93.8 | 11,306.9 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 55.7 | |
| 546.9 | 11,592.5 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 16.8 | |
| 498.3 | 13,063.9 | 2,530.2 | 451.1 | 21.3 | 70.2 | 30.1 | 28.0 | |
| 105.4 | 7,603.8 | 0.0 | -425.4 | -- | -36.7 | -- | 6.0 | |
| 310.4 | 7,699.1 | 0.0 | -303.3 | -- | -45.8 | -- | 8.8 |
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G... protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania. Address: 955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087 Read more
President, CEO & Chairman
Ms. Carrie L. Bourdow
President, CEO & Chairman
Ms. Carrie L. Bourdow
Headquarters
Chesterbrook, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Trevena Inc (TRVN) is $0.01 (NASDAQ) as of 02-Apr-2026 09:30 EDT. Trevena Inc (TRVN) has given a return of -91.41% in the last 3 years.
Since, TTM earnings of Trevena Inc (TRVN) is negative, P/E ratio is not available.
The P/B ratio of Trevena Inc (TRVN) is 0.36 times as on 30-Mar-2026, a 91 discount to its peers’ median range of 3.98 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
-0.01
|
-0.07
|
|
2022
|
-0.38
|
1.30
|
|
2021
|
-0.08
|
0.06
|
|
2020
|
-0.46
|
0.13
|
|
2019
|
-0.13
|
0.11
|
The 52-week high and low of Trevena Inc (TRVN) are Rs 1.38 and Rs 0.00 as of 05-Apr-2026.
Trevena Inc (TRVN) has a market capitalisation of $ 0 Mln as on 30-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Trevena Inc (TRVN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.01
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.